The impact of enzalutamide on quality of life in men with metastatic hormone-sensitive prostate cancer based on prior therapy, risk, and symptom subgroups

  1. Stenzl, A.
  2. Szmulewitz, R.Z.
  3. Petrylak, D.
  4. Holzbeierlein, J.
  5. Villers, A.
  6. Azad, A.
  7. Alcaraz, A.
  8. Alekseev, B.
  9. Iguchi, T.
  10. Shore, N.D.
  11. Gomez-Veiga, F.
  12. Ivanescu, C.
  13. Rosbrook, B.
  14. Ramaswamy, K.
  15. Ganguli, A.
  16. Haas, G.P.
  17. Armstrong, A.J.
Journal:
Prostate

ISSN: 1097-0045,  0270-4137

Year of publication: 2022

Volume: 82

Issue: 13

Pages: 1237-1247

Type: Article

DOI: 10.1002/PROS.24396 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus